Amylyx Pharmaceuticals Inc

AMLX
2,0115
0,0115 (0,57%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
02/5/202415:00BWAmylyx Pharmaceuticals to Report First Quarter 2024..
10/4/202415:00BWAmylyx Pharmaceuticals Announces Interim Data From Ongoing..
09/4/202411:45PRNUSThe Gross Law Firm Notifies Amylyx Pharmaceuticals, Inc...
08/4/202415:00BWAmylyx Pharmaceuticals to Host Virtual Webcast to Discuss..
05/4/202411:45PRNUSAmylyx Pharmaceuticals, Inc. Sued for Securities Law..
04/4/202413:00BWAmylyx Pharmaceuticals Announces Formal Intention to Remove..
02/4/202411:45PRNUSThe Gross Law Firm Reminds Amylyx Pharmaceuticals, Inc...
29/3/202410:45PRNUSThe Gross Law Firm Announces the Filing of a Securities..
26/3/202410:45PRNUSShareholders of Amylyx Pharmaceuticals, Inc. Should Contact..
25/3/202413:00PRNUSINVESTOR ALERT: AMYLYX PHARMACEUTICALS, INC. (NASDAQ: AMLX)..
22/3/202410:45PRNUSThe Gross Law Firm Notifies Shareholders of Amylyx..
19/3/202410:45PRNUSAmylyx Pharmaceuticals, Inc. Sued for Securities Law..
14/3/202414:00BWAmylyx Pharmaceuticals Appoints Bernhardt Zeiher, MD, FCCP,..
14/3/202410:50PRNUSThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff..
11/3/202413:44EDGAR2Form SC 13G - Statement of acquisition of beneficial..
11/3/202410:50PRNUSAmylyx Pharmaceuticals, Inc. Class Action: The Gross Law..
08/3/202413:10EDGAR2Form 8-K - Current report
08/3/202413:00BWAmylyx Pharmaceuticals Announces Topline Results From Global..
07/3/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202411:45PRNUSAmylyx Pharmaceuticals, Inc. Sued for Securities Law..
29/2/202400:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202400:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202400:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202423:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202411:45PRNUSAMLX LAWSUIT ALERT: The Gross Law Firm Notifies Amylyx..
23/2/202422:05BWAmylyx Pharmaceuticals Announces Inducement Grants Under..
22/2/202422:29EDGAR2Form S-8 - Securities to be offered to employees in employee..
22/2/202414:22EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/2/202413:08EDGAR2Form 8-K - Current report
22/2/202413:00BWAmylyx Pharmaceuticals Reports Fourth Quarter and Full Year..
22/2/202411:45PRNUSAmylyx Pharmaceuticals, Inc. Class Action: The Gross Law..
15/2/202422:05BWAmylyx Pharmaceuticals to Report Fourth Quarter and Full..
15/2/202415:00BWAmylyx Pharmaceuticals to Present Updates on its AMX0114 and..
15/2/202411:00PRNUSLost Money on Amylyx Pharmaceuticals, Inc.(AMLX)? Join Class..
08/2/202415:00BWAmylyx Pharmaceuticals Announces Completion of Enrollment in..
11/1/202423:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/1/202423:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202322:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202315:00BWAmylyx Pharmaceuticals Announces First Participant Dosed in..
19/12/202322:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202313:00EDGAR2Form 8-K - Current report
04/12/202315:00BWAmylyx Pharmaceuticals Announces Publication of Data Showing..
29/11/202323:15BWAmylyx Pharmaceuticals Announces Inducement Grants Under..
28/11/202313:00BWAmylyx Pharmaceuticals Appoints Camille L. Bedrosian, MD, as..
27/11/202315:00BWRELYVRIO® and AMX0114 Data to be Presented at 34th..
21/11/202315:00BWAmylyx Pharmaceuticals to Participate at the 6th Annual..
21/11/202302:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202313:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apertura: 2,05 Min: 2,00 Max: 2,13
Chiusura: 2,00

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network